SCHEMBL12468985

SCHEMBL12468985

O=c1c2c[nH]c3c[nH]cc3c-2nn1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ CNR2 P34972 2/20 0.44
▸ CNR1 P21554 1/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42
▸ GAA P10253 2/20 0.42
▸ BCAT1 P54687 1/20 0.38
▸ LMNA P02545 3/20 0.38
▸ HTT P42858 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ ADORA3 P0DMS8 2/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2116450 0.87 CNR2 (0.37) ALDH1A1CNR2CNR1NPSR1GAA
SCHEMBL29896410 0.87 ALDH1A1 (0.50) ALDH1A1CNR2CNR1NPSR1GAA
SCHEMBL1466280 0.87 ALDH1A1 (0.50) ALDH1A1CNR2CNR1NPSR1GAA
SCHEMBL10806776 0.81 ALDH1A1 (0.42) ALDH1A1CNR2CNR1NPSR1GAA
SCHEMBL538414 0.81 TDO2 (0.44) ALDH1A1CNR2CNR1NPSR1GAA
SCHEMBL20150583 0.80 MEN1 (0.57) ALDH1A1NPSR1GAALMNAHTT
SCHEMBL537876 0.80 KDM4E (0.42) ALDH1A1CNR2NPSR1LMNAKDM4E
SCHEMBL1467162 0.80 GABRA1 (0.48) ALDH1A1CNR2GAALMNAHTT
SCHEMBL20150523 0.80 ALDH1A1 (0.43) ALDH1A1CNR2NPSR1GAALMNA
Hydrochloric Acid SCHEMBL10999689 0.80 ALDH1A1 (0.41) ALDH1A1CNR2CNR1NPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627655-B1 FUSED 3-OXO-PYRAZOLO[4,3-c]PYRIDINE COMPOUNDS AS GABAA MODULATORS DART NEUROSCIENCE CAYMAN LTD (KY) 2015-09-16 — — EP disclosed
US-9012470-B2 Therapeutic 5,6,5-tricyclic analogs DART NEUROSCIENCE (CAYMAN) LTD. (KY) 2015-04-21 — — US disclosed
EP-2627655-A2 THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS Dart NeuroScience (Cayman) Ltd (KY) 2013-08-21 — — EP disclosed
WO-2012051213-A2 THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS HELICON THERAPEUTICS, INC. (US) 2012-04-19 — — WO disclosed
Send feedback